HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

alpha-(4-(2-(Dimethylamino)ethoxy)phenyl)-beta-ethyl-alpha-phenylbenzeneethanol

HCID 102478
NotesReactions
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
748-97-0
Standard SMILES
CCC(c1ccccc1)C(O)(c1ccccc1)c1ccc(OCCN(C)C)cc1
InChIKey
VFFBJZCCXOYRNN-UHFFFAOYSA-N
Molecular formula
C26H31NO2
Average molar mass
389.5 g/mol
Monoisotopic mass
389.23547923

Names & identifiers

Preferred name
alpha-(4-(2-(Dimethylamino)ethoxy)phenyl)-beta-ethyl-alpha-phenylbenzeneethanol
IUPAC
1-[4-[2-(dimethylamino)ethoxy]phenyl]-1,2-diphenylbutan-1-ol
English name
alpha-[4-[2-(dimethylamino)ethoxy]phenyl]-beta-ethyl-alpha-phenylphenethyl alcohol
Molecular formula
C26H31NO2
Molecular weight
389.53

Names & synonyms

748-97-01-(4-(2-(Dimethylamino)ethoxy)phenyl)-1,2-diphenylbutan-1-olZF9GQ0WZ9XDTXSID708623991-[4-[2-(dimethylamino)ethoxy]phenyl]-1,2-diphenylbutan-1-ol1-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}-1,2-DIPHENYLBUTAN-1-OLRefChem:555227DTXCID80811171alpha-(4-(2-(Dimethylamino)ethoxy)phenyl)-beta-ethyl-alpha-phenylbenzeneethanol212-023-5Tamoxifen Citrate EP Impurity B(+/-)-1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol
Show more names
Tamoxifen Impurity Btamoxifen citrate impurity BTamoxifen Citrate Impurity 21-[4-(2-Dimethylamino-ethoxy)phenylTamoxifen Citrate Impurity 2(Tamoxifen Citrate EP Impurity B))-1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol1-[4-(2-dimethylaminoethyloxy)phenyl]-1,2-di(phenyl)butan-1-ol(±)-1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol
Tamoxifen EP Impurity Balpha-(4-(2-(Dimethylamino)ethoxy)phenyl)-beta-ethyl-alpha-phenylphenethyl alcoholalpha-[4-[2-(dimethylamino)ethoxy]phenyl]-beta-ethyl-alpha-phenylphenethyl alcoholEINECS 212-023-5UNII-ZF9GQ0WZ9X1-[4-(2-Dimethylamino-ethoxy)phenyl]-1,2-diphenylbutan-1-ol(+/-)-1,2-DIPHENYL-1-(4-(2-(DIMETHYLAMINO)ETHOXY)PHENYL)BUTAN-1-OLTamoxifen Citrate Imp. B (EP); Tamoxifen Imp. B (EP); 1-[4-(2-Dimethylamino-ethoxy)phenyl]-1,2-diphenylbutan-1-ol; Tamoxifen Citrate Impurity B; Tamoxifen Impurity B

Properties

Computed structural properties

XLogP
5.2
Topological polar surface area
32.7 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
9
Heavy atoms
29
Formal charge
0
Complexity
448

Physicochemical properties

Melting point
120 · 120-121℃
Boiling point
504.3 · 504.3±50.0 °C(Predicted)
Density
1.085 · 1.085±0.06 g/cm3(Predicted)
pka
13.31 · 13.31±0.29(Predicted)
FDA UNII
9 GQ0WZ9X · ZF9GQ0WZ9X
Symbol(GHS)
8 · GHS08
Signal word
Danger
Hazard statements
350 · H350
REACH Registrations
Active

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 27.3% (3 of 11) of reports.

Danger

H302 (45.5%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P270, P273, P280, P301+P317, P318, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 11 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationREACH registered substance: α-[4-[2-(dimethylamino)ethoxy]phenyl]-β-ethyl-α-phenylphenethyl alcohol (EC: 212-023-5)
Hazard Classes and CategoriesAcute Tox. 4 (45.5%)

Safety data

Signal word
Danger
Symbol(GHS)
GHS08
Hazard statements
H350
REACH Registrations
Active

Chemistry & industry

Applications

Uses(±)-1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butan-1-ol is an impurity of Tamoxifen (T006000); a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor.

Upstream & downstream products

Downstream products

Tamoxifen citrate

Suppliers28 total

艾吉析科技(上海)有限公司17717235263 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
Baoji Guokang Healthchem co.,ltd+8615604608665 15604608665 · [email protected]
Hangzhou Sage Chemical Co., Ltd.+86057186818502 13588463833 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
孟成科技(上海)有限公司400-820-6829 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
湖北扬信医药科技有限公司15347293736 · [email protected]
深圳摩科生化科技有限公司18627923403 · [email protected]
深圳卓越生物医药科技有限公司

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
748-97-0
PubChem CID
102478
DTXSID
DTXSID70862399
UNII
ZF9GQ0WZ9X
EC Number
212-023-5
Nikkaji
J193.112A
26050679 18318671572 · [email protected]
河南誉康卓宁进出口有限公司13393721940 · [email protected]
BOC Sciences16314854226 · [email protected]
郑州艾克姆化工有限公司0371-0371-55629727 13323845623 · [email protected]
深圳市祥根生物医药有限公司0755-28967200 13631290199 · [email protected]
深圳市华信医药科技有限公司15671363360 · [email protected]
湖北瑞诺医药科技有限公司13165688766 · [email protected]
陕西缔都医药化工有限公司029-81154043 17391733319 · [email protected]
北京爱科姆科技有限公司17710328343 · [email protected]
无锡鸣鹭医药科技有限公司0510-88726693 · [email protected]
career henan chemical co+86-0371-86658258 · [email protected]
湖北摩科化学有限公司18627753421; 18627756402 · [email protected]
常州翔龙医药科技有限公司18661161657 · [email protected]
湖北玖天生物医药科技有限公司027-88013699 17354350817 · [email protected]
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD.+8618950047208 · [email protected]
Shenzhen Excellent Biomedical Technology Co.,Ltd.+86-0755-26050679 15915472436 · [email protected]
上海语锌医药科技有限公司15921286451; 15921286451 · [email protected]
上海择睿生物科技有限公司021-54580889 18321124657 · [email protected]
卡托研究化学公司+86-020-81960175-877 4000-868-328;4000-868-328 · [email protected]